Invista 100 mg Dasatinib (1 pack — 10 tabs)

Buy Invista 100 mg Dasatinib Tablets Online

Invista 100 mg Dasatinib Tablets (1 pack / 10 tabs)

Մի հայացքով

Ընդհանուր անվանում՝ Dasatinib

Բրենդի անվանումը՝ Invista

Հզորությունը և փաթեթի չափը՝ 100 mg per tablet; 1 pack / 10 tablets

Դեղաչափի ձևը և ընդունման եղանակը. Բանավոր դեղահաբ, կուլ տալ ամբողջությամբ ջրով

Թերապևտիկ դաս. Tyrosine kinase inhibitor (BCR-ABL/Src family), targeted anticancer therapy

Հիմնական ցուցում. Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ ՔՄԼ) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ԲՈԼՈՐ)

Մեծահասակների սովորական դեղաչափը. Often 100 mg once daily in adult CML regimens, but dose and schedule are defined by your specialist

Դեղատոմսի կարգավիճակը՝ Միայն դեղատոմսով դեղամիջոց

Պահեստավորում՝ Store below 25-30 °C in the original blister pack, protect from moisture and keep out of reach of children

Արտադրանքի նկարագրություն

Ինվիստա 100 մգ պարունակում է դասատինիբ, an oral targeted medicine used in certain blood cancers driven by abnormal tyrosine kinase signaling. It is prescribed for Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ ՔՄԼ) and for Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ԲՈԼՈՐ) in treatment settings where a specialist decides that դասատինիբ is appropriate. This pack provides 100 mg tablets supplied as 1 pack / 10 tablets, intended to support a planned treatment schedule and routine monitoring as directed by your hematology-oncology team.

Dasatinib is a prescription-only anticancer medicine and is not suitable for self-selection. In CML and Ph+ ԲՈԼՈՐ care, your hematology-oncology team considers disease phase, prior therapies, comorbidities, infection history, bleeding risk, and potential drug interactions before choosing a regimen. Some patients receive դասատինիբ as first-line therapy, while others receive it after resistance or intolerance to another tyrosine kinase inhibitor, and the goals of treatment are always individualized.

Ջեներիկ դեղերի շուկա պարագաներ Ինվիստա 100 մգ դասատինիբ tablets in original manufacturer packaging sourced through licensed channels. The carton and blister typically show the brand name, strength, active ingredient, batch number, and expiry date so your clinic or pharmacy can verify product identity on receipt. Orders are processed with անվտանգ վճարում in USD and shipped in discreet outer packaging to support privacy, with միջազգային առաքում options designed to help patients coordinate refills with specialist monitoring. If you are comparing options, ask your clinic to confirm the correct strength and pack size before ordering and avoid making decisions based only on դասատինիբ price.

Հիմնական կիրառություններ

Ինվիստա 100 մգ դասատինիբ is used to treat Philadelphia chromosome-positive chronic myeloid leukemia, including chronic phase and other phases when a specialist recommends a դասատինիբ-based approach. CML is a myeloproliferative cancer associated with the BCR-ABL fusion protein, and long-term disease control often depends on consistent kinase inhibition together with scheduled laboratory monitoring.

Dasatinib is also used in Philadelphia chromosome-positive acute lymphoblastic leukemia, usually as part of a specialist-led protocol that may include additional medicines. The exact indication, combination strategy, and duration are individualized, and your team will explain how response is assessed, how often blood tests are required, and which symptoms should prompt urgent contact.

Ինչպես է դասատինիբը գործում քիմիաթերապիայի մեջ

Dasatinib inhibits multiple tyrosine kinases, including BCR-ABL and members of the Src family, which are involved in signaling pathways that help malignant cells survive and proliferate. In Philadelphia chromosome-positive disease, BCR-ABL acts like a continuously active switch that drives abnormal cell growth. By blocking this signaling, դասատինիբ can reduce the growth advantage of leukemic cells and help bring blood counts and disease markers under control over time when therapy is taken consistently as prescribed.

Because դասատինիբ is a targeted inhibitor rather than a classic DNA-damaging chemotherapy, its effects and risks differ from many older regimens. Treatment still requires careful monitoring, and side effects can involve blood counts, fluid retention, bleeding tendency, or infections depending on individual risk factors and concomitant medicines. Your specialist balances expected benefit with safety and may adjust therapy based on laboratory trends, symptoms, and known interactions.

Դեղաչափ և կիրառում

Ինվիստա 100 մգ tablets are taken by mouth exactly as prescribed by your hematology-oncology specialist. In adult CML regimens, դասատինիբ is often taken once daily, but the appropriate dose can differ depending on diagnosis, disease phase, response, tolerability, and other medicines. Swallow the tablet whole with water and take it at about the same time each day unless your clinic instructs otherwise.

Drug interactions can be clinically important with դասատինիբ. Certain strong CYP3A inhibitors or inducers may change drug exposure, and some acid-reducing medicines may need careful timing or alternatives because they can affect absorption. Always share a complete list of prescription medicines, over-the-counter products, and supplements with your specialist and pharmacist. If a dose is missed, follow your clinic’s instructions and do not take extra tablets to compensate unless your care team explicitly instructs you to do so.

Նախազգուշական միջոցներ

Dasatinib can cause myelosuppression, meaning reductions in white blood cells, red blood cells, and platelets. Regular blood tests are required, and dose interruptions or adjustments may be needed if cytopenias become significant. Contact your clinic urgently if you develop fever, chills, persistent sore throat, unusual bruising or bleeding, or severe fatigue, as these can signal infection, bleeding, or other complications that need prompt assessment.

Fluid retention is an important risk with դասատինիբ and may present as swelling, rapid weight gain, or pleural effusion with new or worsening cough or breathing difficulty. Some patients may experience pulmonary arterial hypertension, which requires specialist evaluation. Dasatinib may also increase bleeding risk, especially when combined with anticoagulants or antiplatelet medicines. Pregnancy should be avoided during treatment, and contraception planning should be discussed with your specialist before starting therapy.

Դասատինիբի կողմնակի ազդեցությունները

Հաճախակի կողմնակի ազդեցություններ

Ընդհանուր դասատինիբի կողմնակի ազդեցությունները may include headache, diarrhea, nausea, fatigue, muscle or joint aches, skin rash, and mild bruising. Blood tests may show anemia, neutropenia, or thrombocytopenia that require monitoring and, in some cases, supportive care or dose modification. Many effects are manageable when identified early, so report persistent or worsening symptoms rather than adjusting treatment on your own.

Լուրջ կողմնակի ազդեցություններ

Serious side effects require urgent medical attention and can include severe infection, heavy or unusual bleeding, marked shortness of breath, chest pain, or signs of significant fluid retention such as pleural effusion. Severe drops in blood counts, severe skin reactions, and clinically important liver test abnormalities can also occur. If you experience high fever, severe breathing difficulty, fainting, coughing up blood, or rapidly worsening symptoms, seek emergency care and inform clinicians that you are taking դասատինիբ.

Պահեստավորում

Խանութ Ինվիստա 100 մգ below 25-30 °C, protected from moisture and direct heat, and keep the tablets in the original blister pack until use. Keep all medicines out of reach of children. Do not use the tablets after the expiry date printed on the carton or blister, and follow local guidance or your pharmacist’s advice for safe disposal of unused tablets.

Ինչու՞ գնել Ջեներիկ Մեդս Մարթից

Ջեներիկ դեղերի շուկա աջակցում է մասնագիտացված դեղամիջոցների հասանելիությանը և լոգիստիկային, ինչպիսիք են՝ Ինվիստա 100 մգ դասատինիբ tablets. Products are supplied in original packaging from licensed channels with batch and expiry information to support verification by pharmacies and clinics, and discreet packaging helps protect privacy during delivery.

Prices are shown in USD to support planning, orders are processed with անվտանգ վճարում, և Հայաստանում delivery options can help patients coordinate refills with monitoring schedules and specialist visits. Ջեներիկ դեղերի շուկա does not replace your treating doctor; decisions about whether դասատինիբ նպատակահարմարությունը, օգտագործման տևողությունը և կողմնակի ազդեցությունների կառավարման եղանակը պետք է որոշվեն որակյալ առողջապահության մասնագետների կողմից։.

Պատվիրեք հիմա

Քեզանից առաջ buy Invista 100 mg online -ից Ջեներիկ դեղերի շուկա, դուք պետք է ունենաք հաստատված ախտորոշում Ph+ ՔՄԼ կամ Ph+ ԲՈԼՈՐ and a treatment plan agreed with your hematology-oncology specialist. Your care team will advise which monitoring tests are needed and how often, and they will review interaction risks with your current medicines so your դասատինիբի դեղաչափը and schedule are clear.

Once your plan is confirmed, select Ինվիստա 100 մգ (1 pack / 10 tabs), add it to your cart, and complete անվտանգ վճարում in USD. Do not start therapy on your own, and do not stop or change dosing without medical guidance. If you develop concerning symptoms such as heavy bleeding, fever, signs of serious infection, chest pain, or persistent breathing problems, seek urgent medical care and inform clinicians that you are taking դասատինիբ.

Հաճախակի տրվող հարցեր about Invista (Dasatinib)

Հարց 1: What is Invista 100 mg used for?

Ինվիստա 100 մգ պարունակում է դասատինիբ, a tyrosine kinase inhibitor used in Philadelphia chromosome-positive chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia when prescribed by a hematology-oncology specialist.

Հարց 2: How should I take Invista 100 mg tablets?

Invista tablets are taken by mouth on a schedule defined by your specialist. Swallow the tablet whole with water and take it consistently as directed, with or without food depending on your clinic’s instructions.

Հարց 3: Can Invista interact with other medicines?

Yes. Some medicines can change դասատինիբ exposure, and acid-reducing products may require careful timing or alternatives. Share a full list of medicines and supplements with your specialist so safe timing can be planned.

Հարց 4: What should I do if I miss a dose?

If you miss a dose, follow your clinic’s instructions and do not take extra tablets to compensate unless your specialist tells you to. If you are unsure, contact your prescribing team for guidance.

Հարց 5: What monitoring is usually needed during treatment?

Monitoring commonly includes blood counts and clinical checks for infection, bleeding symptoms, and breathing issues related to fluid retention, with frequency defined by your specialist based on your treatment plan.